Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Zach Reitano"


5 mentions found


Ro CEO talks new GLP-1 insurance coverage tool
  + stars: | 2024-08-13 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRo CEO talks new GLP-1 insurance coverage toolZach Reitano, Ro CEO, joins 'Fast Money' to talk the companies new GLP-1 insurance tool.
Persons: Zach Reitano
Ro CEO Zach Reitano talks new GLP-1 supply tracker
  + stars: | 2024-06-04 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRo CEO Zach Reitano talks new GLP-1 supply trackerZach Reitano, Ro co-founder and CEO, joins 'Fast Money' to talk its new GLP-1 supply tracker as demand for weight loss drugs cause shortages.
Persons: Zach Reitano
Dozens of startups have jumped into the weight-loss market this year as weight-loss drugs, including Wegovy and Ozempic, have exploded in popularity. The few companies with enough money and brand recognition to stand up to Ozempic's distribution challenges — WeightWatchers, Noom, and Ro — can expect to compete for market dominance next year. But WeightWatchers signaled it's going all in on weight-loss drugs by launching its own behavioral program for patients on Ozempic in December. WeightWatchersLike WeightWatchers, Noom has remained staunchly in the weight-loss market since its 2008 launch. Ro launched its own program prescribing weight-loss drugs in January.
Persons: VCs, — WeightWatchers, Sari Kaganoff, WeightWatchers, it's, Sima Sistani, Noom, Ro, Zach Reitano, Kaganoff, Saeju Jeong, Sam Barnes, Aaron DeGagne Organizations: Business, Rock Health, Web, Getty, PitchBook Locations: Ozempic
Pivot Point is a new Wall Street Journal feature in which executives reflect on the successes and setbacks of their careers. The first Pivot Point installment is here. Zach Reitano was the only one in his cohort of a dozen summer interns at Booz & Co. a decade ago who didn’t get a full-time job. The failure set him up to lead a $7 billion healthcare company.
Persons: Zach Reitano Organizations: Booz & Co
Salesforce (CRM) downgraded to market perform from outperform (hold from buy) at Cowen, which also cut its price target to $160 per share from $175. Barclays upgrades Ralph Lauren (RL) to overweight from equal weight (buy from hold); increases its price target to $134 per share from $101. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
Total: 5